For: | Gatselis NK, Zachou K, Saitis A, Samara M, Dalekos GN. Individualization of chronic hepatitis C treatment according to the host characteristics. World J Gastroenterol 2014; 20(11): 2839-2853 [PMID: 24659876 DOI: 10.3748/wjg.v20.i11.2839] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i11/2839.htm |
Number | Citing Articles |
1 |
Hui-Chun Li, Shih-Yen Lo. Hepatitis C virus: Virology, diagnosis and treatment. World Journal of Hepatology 2015; 7(10): 1377-1389 doi: 10.4254/wjh.v7.i10.1377
|
2 |
Maria Buti, Rafael Esteban. Hepatitis C virus genotype 3: a genotype that is not ‘easy-to-treat’. Expert Review of Gastroenterology & Hepatology 2015; 9(3): 375 doi: 10.1586/17474124.2015.960396
|
3 |
Christopher R. Jones, Barnaby F. Flower, Ella Barber, Bryony Simmons, Graham S. Cooke. Treatment optimisation for hepatitis C in the era of combination direct-acting antiviral therapy: a systematic review and meta-analysis. Wellcome Open Research 2019; 4: 132 doi: 10.12688/wellcomeopenres.15411.1
|
4 |
Bassem Refaat, Ahmed Mohamed Ashshi, Adel Galal El-Shemi, Esam Azhar, Limin Chen. Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated‐Interferon‐α Based Therapy. Mediators of Inflammation 2015; 2015(1) doi: 10.1155/2015/287640
|
5 |
Martina Smolić, Tea Omanović, Ivana Božić, Ines Bilić-Ćurčić, Robert Smolić, Aleksandar Včev. Update on Hepatitis C. 2017; doi: 10.5772/intechopen.70794
|
6 |
Carolina Scagnolari, Ombretta Turriziani, Katia Monteleone, Alessandra Pierangeli, Guido Antonelli. Consolidation of molecular testing in clinical virology. Expert Review of Anti-infective Therapy 2017; 15(4): 387 doi: 10.1080/14787210.2017.1271711
|